 |
인쇄하기
취소
|
Herceptin approved for treatment of HER2-positive advanced stomach cancer
The Korea Food and Drug Administration has approved Herceptin (trastuzumab) in combination with chemotherapy for use in patients with HER2-positive metastatic stomach (gastric) cancer, Roche Korea said on March 30.
The approval is based on the impressive results from the international ToGA trial (Trastuzumab with chemotherapy in HER2-positive advanced gastric cancer), which showed that treat...
The approval is based on the impressive results from the international ToGA trial (Trastuzumab with chemotherapy in HER2-positive advanced gastric cancer), which showed that treat...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.